Anne Corbett

Summary

Country: UK

Publications

  1. ncbi Treatment of behavioral and psychological symptoms of Alzheimer's disease
    Anne Corbett
    Alzheimer s Society UK, Devon House, London, UK
    Curr Treat Options Neurol 14:113-25. 2012
  2. doi Agitation and aggression in people with Alzheimer's disease
    Clive Ballard
    Wolfson Centre for Age Related Diseases, Guy s Campus, King s College London, London, UK
    Curr Opin Psychiatry 26:252-9. 2013
  3. doi New and emerging treatments for Alzheimer's disease
    Anne Corbett
    Alzheimer s Society, Devon House, London E1W 1JX, UK
    Expert Rev Neurother 12:535-43. 2012
  4. doi Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management
    Clive Ballard
    Wolfson Centre for Age Related Diseases, King s College London, Wolfson Building, Guy s Campus, London, SE1 1UL, UK
    Drugs Aging 30:603-11. 2013
  5. doi New and emerging treatments for Alzheimer's disease
    Anne Corbett
    Alzheimer s Society UK, 58 St Katharine s Way, London E1W 1JX, UK
    Expert Opin Emerg Drugs 17:147-56. 2012
  6. doi Systematic review of services providing information and/or advice to people with dementia and/or their caregivers
    Anne Corbett
    Alzheimer s Society, Devon House, London, UK
    Int J Geriatr Psychiatry 27:628-36. 2012
  7. doi Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial
    Marisa Hanney
    Wolfson Centre for Age Related Diseases, King s College London, London, UK
    Lancet 379:528-36. 2012
  8. doi Alzheimer's disease
    Clive Ballard
    Wolfson Centre for Age Related Diseases, King s College London, London, UK
    Lancet 377:1019-31. 2011
  9. doi Information provision services in dementia care
    Anne Corbett
    Alzheimer s Society Research, London, UK
    Int J Older People Nurs 6:217-26. 2011
  10. doi Management of neuropsychiatric symptoms in people with dementia
    Clive Ballard
    Wolfson Centre for Age Related Diseases, King s College London, London, UK
    CNS Drugs 24:729-39. 2010

Collaborators

Detail Information

Publications11

  1. ncbi Treatment of behavioral and psychological symptoms of Alzheimer's disease
    Anne Corbett
    Alzheimer s Society UK, Devon House, London, UK
    Curr Treat Options Neurol 14:113-25. 2012
    ..Large, prospective, randomized placebo-controlled trials are needed to establish the role of these agents as clinical therapies for the treatment of BPSD...
  2. doi Agitation and aggression in people with Alzheimer's disease
    Clive Ballard
    Wolfson Centre for Age Related Diseases, Guy s Campus, King s College London, London, UK
    Curr Opin Psychiatry 26:252-9. 2013
    ..This review outlines the current evidence for pharmacological and nonpharmacological approaches to the treatment of agitation and aggression in these patients...
  3. doi New and emerging treatments for Alzheimer's disease
    Anne Corbett
    Alzheimer s Society, Devon House, London E1W 1JX, UK
    Expert Rev Neurother 12:535-43. 2012
    ....
  4. doi Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management
    Clive Ballard
    Wolfson Centre for Age Related Diseases, King s College London, Wolfson Building, Guy s Campus, London, SE1 1UL, UK
    Drugs Aging 30:603-11. 2013
    ..Nonpharmacological approaches based on person-centered care and cholinesterase inhibitors should be considered as the first-line treatment for neuropsychiatric symptoms except in extreme cases. ..
  5. doi New and emerging treatments for Alzheimer's disease
    Anne Corbett
    Alzheimer s Society UK, 58 St Katharine s Way, London E1W 1JX, UK
    Expert Opin Emerg Drugs 17:147-56. 2012
    ..It is, therefore, critical to address the current lack of effective treatments to target the underlying pathology and disease process in Alzheimer's disease...
  6. doi Systematic review of services providing information and/or advice to people with dementia and/or their caregivers
    Anne Corbett
    Alzheimer s Society, Devon House, London, UK
    Int J Geriatr Psychiatry 27:628-36. 2012
    ..This study aimed to determine whether information services confer significant benefit for quality of life, neuropsychiatric symptoms and carer burden...
  7. doi Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial
    Marisa Hanney
    Wolfson Centre for Age Related Diseases, King s College London, London, UK
    Lancet 379:528-36. 2012
    ..Evidence to support treatment with Alzheimer's drugs is inadequate, although memantine is beneficial in transgenic mice. We aimed to assess safety and efficacy of memantine on cognition and function in individuals with Down's syndrome...
  8. doi Alzheimer's disease
    Clive Ballard
    Wolfson Centre for Age Related Diseases, King s College London, London, UK
    Lancet 377:1019-31. 2011
    ..In this Seminar, we provide an overview of recent evidence regarding the epidemiology, pathogenesis, diagnosis, and treatment of Alzheimer's disease, and discuss potential ways to reduce the risk of developing the disease...
  9. doi Information provision services in dementia care
    Anne Corbett
    Alzheimer s Society Research, London, UK
    Int J Older People Nurs 6:217-26. 2011
    ....
  10. doi Management of neuropsychiatric symptoms in people with dementia
    Clive Ballard
    Wolfson Centre for Age Related Diseases, King s College London, London, UK
    CNS Drugs 24:729-39. 2010
    ..Adequately powered randomized controlled trials for the treatment of clinically significant agitation are urgently needed to explore alternative pharmacological therapies...
  11. doi Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality
    Clive Ballard
    Wolfson Centre for Age Related Diseases, Wolfson Wing, King s College London, Guy s Campus, Hodgkin Building, London, UK
    Expert Opin Drug Saf 10:35-43. 2011
    ..The benefits are less clear-cut with longer term prescribing, but the mortality risk remains significantly elevated. Pharmacogenetics may provide an opportunity to more effectively focus prescribing in the future...